Imbio RV/LV Software vs Eko Low Ejection Fraction Tool (ELEFT)

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

AI Verdict

Tool A is an imaging AI solution for radiologists and cardiologists, analyzing CTPA scans to measure ventricular diameters for risk stratification in pulmonary conditions. Conversely, Tool B is a clinical decision support tool for a broader range of clinicians, integrating with digital stethoscopes to detect low ejection fraction during routine physical exams. While both are FDA-cleared cardiology AI tools, their distinct data inputs and specific clinical use cases make them adjacent rather than direct competitors.

Choose Imbio RV/LV Software if…

Choose Imbio RV/LV Software if your clinical workflow involves frequent CTPA scans and you require automated, precise measurements of right and left ventricular diameters for risk stratification of pulmonary conditions, such as pulmonary embolism. This tool is ideal for radiology departments seeking to streamline image analysis and integrate ventricular ratio reporting directly into their PACS for efficient decision-making.

View Imbio RV/LV Software →

Choose Eko Low Ejection Fraction Tool (ELEFT) if…

Choose Eko Low Ejection Fraction Tool (ELEFT) if you are a clinician seeking a non-invasive, point-of-care screening tool to aid in the early detection of low ejection fraction during routine physical exams. This solution is best suited for primary care or cardiology settings where rapid assessment of heart failure risk using a digital stethoscope can inform timely referrals and interventions.

View Eko Low Ejection Fraction Tool (ELEFT) →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Imbio RV/LV Software Eko Low Ejection Fraction Tool (ELEFT)
Deployment Cloud-based, Locally virtualized (virtual machine, Docker), or through partners like Aidoc, Blackford Analysis, and Philips Healthcare. [9, 27] Unknown
FDA Status Yes AI-estimated Cleared AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Imbio RV/LV Software

Imbio RV/LV Software offers a fully automated workflow that integrates directly into existing PACS systems, requiring no user intervention after the scan is complete. This minimizes disruption to a radiologist's workflow. Eko ELEFT, while providing quick results, requires active use of a digital stethoscope during a physical exam.

Clinical Value

Eko Low Ejection Fraction Tool (ELEFT)

Both tools offer significant clinical value by aiding in the detection and risk stratification of serious cardiac and pulmonary conditions. However, Eko ELEFT provides specific clinical validation metrics (AUROC of 0.835, 75% sensitivity, and 78% specificity) from a multi-site prospective study, demonstrating its effectiveness in early heart failure detection at the point of care.

Pricing & Value

Imbio RV/LV Software

Imbio RV/LV Software offers more transparency regarding its pricing model, stating it is subscription-based and dependent on the number of analyses and installations. This provides potential customers with a clearer understanding of the cost drivers. Eko ELEFT requires direct contact for pricing, which offers less upfront information.

Enterprise Readiness

Imbio RV/LV Software

Both tools are FDA-cleared and HIPAA compliant, indicating foundational enterprise readiness. However, Imbio RV/LV Software offers more flexible deployment options, including cloud, on-premise, and integration with numerous partner platforms, along with explicit DICOM compliance, which is critical for seamless integration into diverse hospital IT infrastructures.

Innovation

Eko Low Ejection Fraction Tool (ELEFT)

While both leverage AI, Eko ELEFT demonstrates greater innovation by integrating AI directly into a routine physical examination tool (digital stethoscope) for early detection of heart failure risk. This approach brings advanced diagnostic capabilities to the point of care, potentially enabling earlier intervention and broader accessibility.

Support & Docs

Tie

Both companies provide comprehensive support options. Imbio explicitly states 24/7/365 support via email and website tickets, along with a hotline during business hours. Eko Health offers a robust online help center with FAQs, user manuals, and the ability to schedule support calls, indicating strong customer support infrastructure.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Imbio RV/LV Software Eko Low Ejection Fraction Tool (ELEFT)
Tool Name Imbio RV/LV Software Eko Low Ejection Fraction Tool (ELEFT)
Company Imbio Eko Health
Description AI-powered tool that automatically measures right and left ventricular diameters from CTPA scans, providing a ratio to aid in risk stratification for pulmonary conditions like pulmonary embolism. FDA-cleared AI algorithm that integrates with Eko digital stethoscopes to aid clinicians in the early detection of low ejection fraction, a key indicator of heart failure, during routine physical exams.
Primary Input Data CTPA scans ECG and heart sound recordings (via Eko digital stethoscopes)
Key Measurement/Detection Automated measurement of right and left ventricular diameters, RV/LV ratio AI-powered low ejection fraction detection
Specialties Cardiology, Pulmonology, Radiology Cardiology, Family Medicine, Internal Medicine

Videos

Demos, reviews, and walkthroughs featuring Imbio RV/LV Software and Eko Low Ejection Fraction Tool (ELEFT).

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Imbio RV/LV Software is designed to measure right and left ventricular diameters from CTPA scans, providing a ratio to aid in risk stratification for pulmonary conditions like pulmonary embolism. Eko Low Ejection Fraction Tool (ELEFT) aids clinicians in the early detection of low ejection fraction, a key indicator of heart failure, during routine physical exams.
Imbio RV/LV Software requires DICOM compliant CTPA scans as input. Eko Low Ejection Fraction Tool (ELEFT) integrates with Eko digital stethoscopes and analyzes ECG and heart sound recordings.
Imbio RV/LV Software offers a fully automated workflow, with results available directly in standard reading environments like PACS, without requiring user intervention after scan completion. Eko Low Ejection Fraction Tool (ELEFT) integrates with FDA-cleared Eko digital stethoscopes and provides results in approximately 15 seconds during a routine physical exam as part of the SENSORAu2122 platform.
Imbio RV/LV Software is designed for Cardiology, Pulmonology, and Radiology. Eko Low Ejection Fraction Tool (ELEFT) targets Cardiology, Family Medicine, and Internal Medicine.
Imbio RV/LV Software calculates and reports the RV/LV ratio, provides annotated images showing ventricular measurements, and generates summary PDF reports. Eko Low Ejection Fraction Tool (ELEFT) provides AI-powered detection of low ejection fraction.

Backers

Who funded each tool's parent company.

Eko Low Ejection Fraction Tool (ELEFT)

AI Tool Finder
AI-powered search. Results may not be comprehensive.